Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vas Narasimhan
Pharma
Novartis CEO echoes call for EU drug pricing reform
Novartis CEO Vas Narasimhan says that Europe needs a “complete rethink” on how it prices its drugs and warned that patient access is at stake.
Kevin Dunleavy
Apr 28, 2026 4:46pm
Novartis CEO Vas Narasimhan joins Anthropic's board
Apr 15, 2026 10:36am
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
Novartis CEO pay soars 30% to $32M in 2025
Feb 9, 2026 3:54pm
Novartis CEO eyes 2026 growth despite record patent cliff
Feb 4, 2026 2:30pm
Newer drugs came to Novartis' aid as top-selling brands stalled
Oct 28, 2025 11:18am
